Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
Denkinger CM, Janssen M, Schäkel U, Gall J, Leo A, Stelmach P, Weber SF, Krisam J, Baumann L, Stermann J, Merle U, Weigand MA, Nusshag C, Bullinger L, Schrezenmeier JF, Bornhäuser M, Alakel N, Witzke O, Wolf T, Vehreschild MJGT, Schmiedel S, Addo MM, Herth F, Kreuter M, Tepasse PR, Hertenstein B, Hänel M, Morgner A, Kiehl M, Hopfer O, Wattad MA, Schimanski CC, Celik C, Pohle T, Ruhe M, Kern WV, Schmitt A, Lorenz HM, Souto-Carneiro M, Gaeddert M, Halama N, Meuer S, Kräusslich HG, Müller B, Schnitzler P, Parthé S, Bartenschlager R, Gronkowski M, Klemmer J, Schmitt M, Dreger P, Kriegsmann K, Schlenk RF, Müller-Tidow C. Denkinger CM, et al. Among authors: schmitt m, schmitt a. Nat Cancer. 2023 Jan;4(1):96-107. doi: 10.1038/s43018-022-00503-w. Epub 2022 Dec 29. Nat Cancer. 2023. PMID: 36581734 Free PMC article. Clinical Trial.
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.
Ringhoffer M, Wiesneth M, Harsdorf S, Schlenk RF, Schmitt A, Reinhardt PP, Moessner M, Grimminger W, Mertens T, Reske SN, Döhner H, Bunjes D. Ringhoffer M, et al. Among authors: schmitt a. Br J Haematol. 2004 Aug;126(4):527-35. doi: 10.1111/j.1365-2141.2004.05062.x. Br J Haematol. 2004. PMID: 15287946 Free article.
Dendritic cell vaccines for leukemia patients.
Schmitt A, Hus I, Schmitt M. Schmitt A, et al. Among authors: schmitt m. Expert Rev Anticancer Ther. 2007 Mar;7(3):275-83. doi: 10.1586/14737140.7.3.275. Expert Rev Anticancer Ther. 2007. PMID: 17338648 Review.
Peptide vaccines for patients with acute myeloid leukemia.
Schmitt M, Casalegno-Garduño R, Xu X, Schmitt A. Schmitt M, et al. Among authors: schmitt a. Expert Rev Vaccines. 2009 Oct;8(10):1415-25. doi: 10.1586/erv.09.90. Expert Rev Vaccines. 2009. PMID: 19803762 Review.
Multimer technologies for detection and adoptive transfer of antigen-specific T cells.
Casalegno-Garduño R, Schmitt A, Yao J, Wang X, Xu X, Freund M, Schmitt M. Casalegno-Garduño R, et al. Among authors: schmitt m, schmitt a. Cancer Immunol Immunother. 2010 Feb;59(2):195-202. doi: 10.1007/s00262-009-0778-4. Epub 2009 Oct 22. Cancer Immunol Immunother. 2010. PMID: 19847424 Free PMC article. Review.
Effects of nilotinib on regulatory T cells: the dose matters.
Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Greiner J, Götz M, Bunjes D, Schmitt M. Fei F, et al. Among authors: schmitt m, schmitt a. Mol Cancer. 2010 Jan 29;9:22. doi: 10.1186/1476-4598-9-22. Mol Cancer. 2010. PMID: 20113470 Free PMC article.
Targeted cellular immunotherapy for leukemia patients.
Casalegno-Garduño R, Schmitt A, Wang X, Xu X, Schmitt M. Casalegno-Garduño R, et al. Among authors: schmitt m, schmitt a. Transfus Apher Sci. 2010 Oct;43(2):207-10. doi: 10.1016/j.transci.2010.07.022. Epub 2010 Aug 1. Transfus Apher Sci. 2010. PMID: 20678962
1,800 results